Literature DB >> 8218057

Cataract and myotonic dystrophy: the role of molecular diagnosis.

W Reardon1, J C MacMillan, J Myring, H G Harley, S A Rundle, L Beck, P S Harper, D J Shaw.   

Abstract

Myotonic dystrophy (dystrophia myotonica), the commonest and most variable of the muscular dystrophies of adult life, has long been known to be associated with cataract, while slit-lamp examination for specific lens opacities has been one of the principal methods of presymptomatic detection of gene carriers. The recent discovery that the myotonic dystrophy mutation is an unstable DNA sequence, composed of varying numbers of CTG triplet repeats, now allows a specific molecular test for this disorder, as well as explaining the phenomenon of anticipation. A series of case reports is presented to illustrate the important practical applications of this development in relation to ophthalmic aspects of the disorder. Reassessment of the specificity of the ophthalmic changes may be required and it will be important for molecular analysis to be used alongside ophthalmic studies, when determining whether family members carry the mutation for myotonic dystrophy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8218057      PMCID: PMC513956          DOI: 10.1136/bjo.77.9.579

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  Five years experience of predictive testing for myotonic dystrophy using linked DNA markers.

Authors:  W Reardon; J L Floyd; J Myring; L P Lazarou; A L Meredith; P S Harper
Journal:  Am J Med Genet       Date:  1992-08-01

2.  Presymptomatic detection and prenatal diagnosis for myotonic dystrophy by means of linked DNA markers.

Authors:  A M Norman; J L Floyd; A L Meredith; P S Harper
Journal:  J Med Genet       Date:  1989-12       Impact factor: 6.318

3.  Pre-symptomatic detection and genetic counselling in myotonic dystrophy.

Authors:  P S Harper
Journal:  Clin Genet       Date:  1973       Impact factor: 4.438

4.  Early recognition of heterozygotes for the gene for dystrophia myotonica.

Authors:  S Bundey; C O Carter; J F Soothill
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-06       Impact factor: 10.154

5.  Anticipation in myotonic dystrophy: new light on an old problem.

Authors:  P S Harper; H G Harley; W Reardon; D J Shaw
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

6.  Myotonic dystrophy. Predictive value of normal results on clinical examination.

Authors:  H G Brunner; H J Smeets; W Nillesen; B A van Oost; J B van den Biezenbos; E M Joosten; A J Pinckers; B C Hamel; A G Theeuwes; B Wieringa
Journal:  Brain       Date:  1991-10       Impact factor: 13.501

7.  Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy.

Authors:  J Buxton; P Shelbourne; J Davies; C Jones; T Van Tongeren; C Aslanidis; P de Jong; G Jansen; M Anvret; B Riley
Journal:  Nature       Date:  1992-02-06       Impact factor: 49.962

8.  Cloning of the essential myotonic dystrophy region and mapping of the putative defect.

Authors:  C Aslanidis; G Jansen; C Amemiya; G Shutler; M Mahadevan; C Tsilfidis; C Chen; J Alleman; N G Wormskamp; M Vooijs
Journal:  Nature       Date:  1992-02-06       Impact factor: 49.962

9.  Diagnostic value of ophthalmologic findings in myotonic dystrophy: comparison with risks calculated by haplotype analysis of closely linked restriction fragment length polymorphisms.

Authors:  T Ashizawa; J F Hejtmancik; J Liu; M B Perryman; H F Epstein; D D Koch
Journal:  Am J Med Genet       Date:  1992-01-01

10.  Application of a closely linked polymorphism of restriction fragment length to counselling and prenatal testing in families with myotonic dystrophy.

Authors:  A L Meredith; S M Huson; P W Lunt; M Sarfarazi; H G Harley; J D Brook; D J Shaw; P S Harper
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-22
View more
  4 in total

1.  Myotonic dystrophy type 1-associated CTG repeats disturb the expression and subcellular distribution of microtubule-associated proteins MAP1A, MAP2, and MAP6/STOP in PC12 cells.

Authors:  Prisiliana Velázquez-Bernardino; Francisco García-Sierra; Oscar Hernández-Hernández; Mario Bermúdez de León; Geneviève Gourdon; Mário Gomes-Pereira; Bulmaro Cisneros
Journal:  Mol Biol Rep       Date:  2011-05-13       Impact factor: 2.316

2.  Endocrine function in 97 patients with myotonic dystrophy type 1.

Authors:  M C Ørngreen; P Arlien-Søborg; M Duno; J M Hertz; J Vissing
Journal:  J Neurol       Date:  2012-02-17       Impact factor: 4.849

Review 3.  Presymptomatic testing for genetic diseases of later life. Pharmacoepidemiological considerations.

Authors:  B J Rossiter; C T Caskey
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

4.  Orthopaedic Disorders in Myotonic Dystrophy Type 1: descriptive clinical study of 21 patients.

Authors:  Lisa Schilling; Raimund Forst; Jürgen Forst; Albert Fujak
Journal:  BMC Musculoskelet Disord       Date:  2013-12-01       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.